{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:39:43Z","timestamp":1773265183363,"version":"3.50.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"\n Objective<\/jats:title>\n \n The\n KLF11<\/jats:italic>\n gene can cause maturity-onset diabetes of the young type 7 (MODY7). Currently, there are few reports on MODY7 cases and their clinical and functional characteristics. This study aimed to analyze the clinical and functional features of the\n KLF11<\/jats:italic>\n R29Q variant to provide a basis for the diagnosis and treatment of this disease.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n Clinical baseline data of patients were collected, and high\u2212throughput sequencing (NGS) was used to screen probands clinically suspected of harboring\n KLF11<\/jats:italic>\n variants, with validation performed in their family members. A luciferase reporter assay was used to test whether the\n KLF11<\/jats:italic>\n R29Q variant binds to the insulin promoter. Real-time PCR, western blotting, and glucose-stimulated insulin secretion (GSIS) assays were employed to analyze insulin expression and insulin secretion activity in \u03b2-cell lines.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n 1) Clinical data showed that Proband 1 presented with insulin dependence, severe hyperlipidemia, diabetic retinopathy, and cataract at the initial stage of the disease. A relatively high dose of insulin was required and could not be completely discontinued; after insulin treatment, glucose and lipid metabolic disorders and visual acuity were improved. Proband 2 exhibited poor islet function at early onset, accompanied by diabetic autonomic neuropathy and peripheral neuropathy, and glycemic control remained unsatisfactory despite insulin therapy. 2) Genetic testing demonstrated that the heterozygous\n KLF11<\/jats:italic>\n R29Q variant was identified in Proband 1, her father, and her elder sister, as well as in Proband 2 and her mother. The elder sister of Proband 1 was in a prediabetic state, whereas this variant was not detected in Proband 1\u2019s mother or younger brother. The mother of Proband 2 had normal blood glucose levels and displayed no diabetes-related clinical manifestations. 3) Protein three-dimensional structure predictions indicated that the\n KLF11<\/jats:italic>\n R29Q mutation affects the electrostatic potential on the surface of the\n KLF11<\/jats:italic>\n protein molecule, disrupting its tertiary structure and compromising protein stability. 4) Cell-based luciferase reporter assays using wild-type and mutant constructs demonstrated that the\n KLF11<\/jats:italic>\n R29Q variant had impaired insulin promoter regulatory activity. Furthermore, real-time PCR, western blotting, and GSIS analyses indicated that this variant impairs insulin expression in pancreatic \u03b2-cells and inhibits insulin secretion.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n \n We studied a\n KLF11<\/jats:italic>\n R29Q single-gene mutation associated with MODY7. The study confirmed that this variant has impaired insulin promoter regulatory activity and inhibits insulin expression and secretion.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fendo.2026.1781016","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:35:29Z","timestamp":1773207329000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and functional characteristics of the KLF11 (p.R29Q) variant associated with MODY7"],"prefix":"10.3389","volume":"17","author":[{"given":"Yidan","family":"Qiao","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Geriatric Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guijun","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes-2023","volume":"46","author":"Elsayed","year":"2023","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409177102","article-title":"Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function","volume":"102","author":"Neve","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg470","article-title":"An mSin3A interaction domain links the transcriptional activity of KLF11 with its role in growth regulation","volume":"22","author":"Fernandez-Zapico","year":"2003","journal-title":"EMBO J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00253","article-title":"Genetic testing of maturity-onset diabetes of the young current status and future perspectives","volume":"9","author":"Firdous","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B5","article-title":"Maturity onset diabetes of the young: clinical characteristics, diagnosis and management","volume":"10","author":"Kavvoura","year":"2012","journal-title":"Pediatr Endocrinol Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"d6044","DOI":"10.1136\/bmj.d6044","article-title":"Diagnosis and management of maturity onset diabetes of the young (MODY)","volume":"343","author":"Thanabalasingham","year":"2011","journal-title":"BMJ"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K08E-302","article-title":"Identification of minimal promoter and genetic variants of Kruppel-like factor 11 gene and association analysis with type 2 diabetes in Japanese","volume":"56","author":"Kuroda","year":"2009","journal-title":"Endocr J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/pedi.13384","article-title":"A novel KLF11 variant in a family with maturity-onset diabetes of the young","volume":"23","author":"Wu","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075311","article-title":"Role for Kr\u00fcppel-like transcription factor 11 in mesenchymal cell function and fibrosis","volume":"8","author":"Mathison","year":"2013","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.215822","article-title":"Disruption of a novel Kruppel-like transcription factor p300-regulated pathway for insulin biosynthesis revealed by studies of the c.-331 INS mutation found in neonatal diabetes mellitus","volume":"286","author":"Bonnefond","year":"2011","journal-title":"J Biol Chem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13426","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents","volume":"23","author":"Greeley","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2009.02812.x","article-title":"Testing for monogenic diabetes among children and adolescents with antibody-negative clinically defined Type 1 diabetes","volume":"26","author":"Rubio-Cabezas","year":"2009","journal-title":"Diabetes Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2010.00681.x","article-title":"Persistently autoantibody negative (PAN) type 1 diabetes mellitus in children","volume":"12","author":"Hameed","year":"2011","journal-title":"Pediatr Diabetes"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2012.00917.x","article-title":"Identification of INS and KCNJ11 gene mutations in type 1B diabetes in Japanese children with onset of diabetes before 5 years of age","volume":"14","author":"Moritani","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12868","article-title":"KLF11 variant in a family clinically diagnosed with early childhood-onset type 1B diabetes","volume":"20","author":"Ushijima","year":"2019","journal-title":"Pediatr Diabetes"},{"key":"B16","doi-asserted-by":"publisher","first-page":"7136869","DOI":"10.1155\/2021\/7136869","article-title":"Clinical and functional characteristics of a novel KLF11 cys354Phe variant involved in maturity-onset diabetes of the young","volume":"2021","author":"Sun","year":"2021","journal-title":"J Diabetes Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s43657-021-00030-1","article-title":"Beyond Mendelian inheritance: genetic buffering and phenotype variability","volume":"2","author":"Rossi","year":"2022","journal-title":"Phenomics"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.920390","article-title":"Incomplete penetrance and variable expressivity: from clinical studies to population cohorts","volume":"13","author":"Kingdom","year":"2022","journal-title":"Front Genet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"8318","DOI":"10.1038\/s41467-023-43878-9","article-title":"Polygenic risk alters the penetrance of monogenic kidney disease","volume":"14","author":"Khan","year":"2023","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-025-01372-0","article-title":"Common genetic variants modify disease risk and clinical presentation in monogenic diabetes","volume":"7","author":"Murray Leech","year":"2025","journal-title":"Nat Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41588-025-02175-5","article-title":"Author Correction: Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genes","volume":"57","author":"Huerta-Chagoya","year":"2025","journal-title":"Nat Genet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S179793","article-title":"Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment","volume":"12","author":"Urakami","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.12701\/yujm.2019.00409","article-title":"Maturity-onset diabetes of the young: update and perspectives on diagnosis and treatment","volume":"37","author":"Jang","year":"2020","journal-title":"Yeungnam Univ J Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1781016\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:35:30Z","timestamp":1773207330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1781016\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":23,"alternative-id":["10.3389\/fendo.2026.1781016"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1781016","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"article-number":"1781016"}}